Novartis AG has sold its entire shareholding of Novartis India Limited, representing 70.68% of the equity share capital, to WaveRise Investments Limited, ChrysC ...
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade1-3 HS often emerges around puberty, underscoring importance of early diagn ...
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade1-3 HS often emerges around puberty, underscoring importance of early ...
In his first and exclusive interview after Novartis AG's decision to sell its stake in Novartis India Limited, Novartis India Country President and Managing Director Amitabh Dube tells Business Today ...
Novartis, Celanese, Eli Lilly and Hyundai have opened AI-dedicated centres to explore automation of internal processes and segments. New AI tools that can automate finance, legal, HR, and software ...
Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
- Transformative year for tau in AD: VY1706 clinical entry and VY7523 clinical data anticipated H2 2026 - - Validating brain-targeted capsids in humans: expect two I.V.-delivered neuro gene therapies ...
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription ...
Top 30 pharma companies post 12% revenue growth in first nine months, net profit up only by 2.8%: Sanjay Pingle, Mumbai Friday, March 13, 2026, 08:00 Hrs [IST] The aggregate finan ...
Zacks Investment Research on MSN
Incyte (INCY) down 4.2% since last earnings report: Can it rebound?
A month has gone by since the last earnings report for Incyte (INCY). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to ...
Novartis (SWX:NOVN) shareholders approved changes to the Board at the recent AGM, including the appointment of a ...
By Ariane Luthi ZURICH, March 9 (Reuters) - UBS kept CEO Sergio Ermotti's total compensation steady at 14.9 million Swiss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results